Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Ischemic Stroke ll: Pathophysiology

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...

Ischemic Stroke l: Introduction

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.

Cerebral Edema ll: Pathophysiology

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...

Sleep-Wake Cycles

Sleep-Wake Cycles

Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:

Transient Ischemic Attack l: Introduction

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...

Increased Intracranial Pressure ll: Pathophysiology

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Results of the observational program CITOTREK (use of the drug CITOflavin in Tablets) in patients with tension headaches against the backgRound of asthenic syndromE taKing into account comorbidity].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025

Same author

[Potential of animal-derived neuropeptides in complex therapy of diabetic neuropathy in patients with type 2 diabetes mellitus].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025

Same author

[Results of a pilot study of the structure and evaluation of the therapy for chronic sleep disorders in comorbid patients with chronic cerebral ischemia].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2024

Same author

[The use of neuropeptides of animal origin in the treatment of neurological diseases].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2023

Same author

[A complex of B vitamins, choline and inosine in the treatment of chronic pain].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2023

Same author

[Pathogenetic approaches to the treatment of sleep disorders in comorbid patients].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2022

Search research articles

Related Experiment Video

Updated: Jun 11, 2026

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice

Published on: September 22, 2020

[Sleep disorders and chronic cerebral ischemia].

¹Pirogov Russian National Research Medical University, Moscow, Russia.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova

|June 10, 2026

Summary

Chronic cerebral ischemia and insomnia frequently coexist, worsening patient outcomes. The combination drug Cytoflavin shows promise in managing these comorbid conditions, improving sleep and cognitive function.

Keywords:

Cytoflavin chronic cerebral ischemia comorbidity insomnia sleep disorders

More Related Videos

Lateral Chronic Cranial Window Preparation Enables In Vivo Observation Following Distal Middle Cerebral Artery Occlusion in Mice

Lateral Chronic Cranial Window Preparation Enables In Vivo Observation Following Distal Middle Cerebral Artery Occlusion in Mice

Published on: December 29, 2016

Cerebral Ischemic Coma Model Induced by Modified Four-Vessel Occlusion

Cerebral Ischemic Coma Model Induced by Modified Four-Vessel Occlusion

Published on: July 5, 2024

Related Experiment Videos

Last Updated: Jun 11, 2026

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice

Published on: September 22, 2020

Lateral Chronic Cranial Window Preparation Enables In Vivo Observation Following Distal Middle Cerebral Artery Occlusion in Mice

Lateral Chronic Cranial Window Preparation Enables In Vivo Observation Following Distal Middle Cerebral Artery Occlusion in Mice

Published on: December 29, 2016

Cerebral Ischemic Coma Model Induced by Modified Four-Vessel Occlusion

Cerebral Ischemic Coma Model Induced by Modified Four-Vessel Occlusion

Published on: July 5, 2024

Area of Science:

Neurology
Sleep Medicine
Pharmacology

Background:

Chronic cerebral ischemia affects a significant portion of the adult population, increasing with age.
Sleep disorders are globally prevalent, impacting approximately 1 billion individuals.
The comorbidity of chronic cerebral ischemia and sleep disorders exacerbates symptoms and reduces quality of life.

Purpose of the Study:

To investigate the pathogenic relationship between chronic cerebral ischemia and sleep disorders.
To evaluate the therapeutic potential of Cytoflavin in patients with comorbid chronic cerebral ischemia and insomnia.

Main Methods:

Literature review on chronic cerebral ischemia and sleep disorders.
Analysis of clinical data regarding the efficacy of Cytoflavin in comorbid conditions.
Assessment of Cytoflavin's safety profile compared to traditional hypnotics.

Main Results:

Cytoflavin demonstrated efficacy in alleviating acute insomnia and preventing its chronic progression.
The drug was shown to reduce side effects associated with hypnotic medications.
Improvements in cognitive-behavioral functioning and anxiety reduction were observed with Cytoflavin use.

Conclusions:

Cytoflavin is a promising therapeutic option for patients suffering from chronic cerebral ischemia and insomnia.
Its use may offer a safer alternative to hypnotics, with added benefits for cognitive function.
Further research into Cytoflavin's role in managing comorbid neurological and sleep conditions is warranted.